TCGX secures $600M for its first Asia life sciences fund
DealStreetAsia · 2026-10-09
US healthcare investor TCGX secured $600M in commitments for TCGX Asia Life Sciences Fund I, backing Asian biotechs at all stages that develop drugs for global markets. It is opening offices in Shanghai and Hong Kong, signaling global capital's bet on Asia's early-stage drug discovery.
Vocabulary
Read source ↗- flagship fundsa firm's main, core funds
- institutional investorslarge organizations that invest, like pensions and insurers
- drug discoverythe research process of finding new medicines